In a murine lung cancer model, IL‐7 + sCD127 treatment enhanced antigen presentation, T‐cell activity and inflammation in the tumor microenvironment which reduced tumor burden and improved survival compared with IL‐7 alone.18 Here, IL7 is linked to lung cancer.